Yesterday, Salix Pharmaecuticals accepted Valeant’s raised takeover offer of $10.96 billion in cash, ending the bidding war between Endo and Valeant for the gastrointestinal drug maker. Valeant’s new offer of $173 per share is about a 10% increase over its original offer of $158 per share. Valeant also paid $296 million for assets of bankrupt …
NY Times – DealB%k
- How Donald Trump Went From Calling for a TikTok Ban to Backing Off December 29, 2024In 2020, he moved to ban the Chinese-owned app. Now, he is opposing the Biden administration’s effort to do just that.
- Richard Parsons, Serial Fixer of Media and Finance Giants, Dies at 76 December 28, 2024His résumé is a catalog of corporate emergencies at Time Warner, Citigroup and the Los Angeles Clippers.
- Yellen Issues Debt Limit Warning to Congress December 27, 2024The Treasury secretary urged Congress to protect the full faith and credit of the United States by raising the debt limit.